Works matching AU Jacobs, Tom


Results: 98
    1
    2

    First-Line Antituberculosis Drug Concentrations in Infants With HIV and a History of Recent Admission With Severe Pneumonia.

    Published in:
    Journal of the Pediatric Infectious Diseases Society, 2023, v. 12, n. 11, p. 581, doi. 10.1093/jpids/piad088
    By:
    • Chabala, Chishala;
    • Jacobs, Tom G;
    • Moraleda, Cinta;
    • Ndaferankhande, John M;
    • Mumbiro, Vivian;
    • Passanduca, Alfeu;
    • Namuziya, Natasha;
    • Nalwanga, Damalie;
    • Musiime, Victor;
    • Ballesteros, Alvaro;
    • Domínguez-Rodríguez, Sara;
    • Chitsamatanga, Moses;
    • Cassia, Uneisse;
    • Nduna, Bwendo;
    • Bramugy, Justina;
    • Sacarlal, Jahit;
    • Madrid, Lola;
    • Nathoo, Kusum J;
    • Colbers, Angela;
    • Burger, David M
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10

    P1‐052: A SINGLE ASCENDING DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF THE ANTI‐PHOSPHO‐TAU ANTIBODY JNJ‐63733657 IN HEALTHY SUBJECTS.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P252, doi. 10.1016/j.jalz.2019.06.077
    By:
    • Galpern, Wendy R.;
    • Mercken, Marc;
    • Van Kolen, Kristof;
    • Timmers, Maarten;
    • Haeverans, Katrin;
    • Janssens, Luc;
    • Triana-Baltzer, Gallen;
    • Kolb, Hartmuth C.;
    • Jacobs, Tom;
    • Nandy, Partha;
    • Malia, Thomas;
    • Sun, Hong;
    • Van Nueten, Luc
    Publication type:
    Article
    11

    Brivaracetam Disposition in Renal Impairment.

    Published in:
    Journal of Clinical Pharmacology, 2012, v. 52, n. 12, p. 1927, doi. 10.1177/0091270011431457
    By:
    • Sargentini-Maier, Maria Laura;
    • Sokalski, Antoni;
    • Boulanger, Pierre;
    • Jacobs, Tom;
    • Stockis, Armel
    Publication type:
    Article
    12
    13
    14

    Robbing Peter to pay Paul.

    Published in:
    Nature Biotechnology, 2006, v. 24, n. 11, p. 1341, doi. 10.1038/nbt1106-1341
    By:
    • Jacobs, Tom
    Publication type:
    Article
    15

    Biotech buybacks—good or bad?

    Published in:
    Nature Biotechnology, 2006, v. 24, n. 10, p. 1207, doi. 10.1038/nbt1006-1207
    By:
    • Jacobs, Tom
    Publication type:
    Article
    16

    The protection racket.

    Published in:
    Nature Biotechnology, 2006, v. 24, n. 9, p. 1081, doi. 10.1038/nbt0906-1081
    By:
    • Jacobs, Tom
    Publication type:
    Article
    17
    18
    19

    A special biotech speculation.

    Published in:
    Nature Biotechnology, 2006, v. 24, n. 6, p. 622, doi. 10.1038/nbt0606-622
    By:
    • Jacobs, Tom
    Publication type:
    Article
    20

    PEGging biotech growth.

    Published in:
    Nature Biotechnology, 2006, v. 24, n. 5, p. 506, doi. 10.1038/nbt0506-506
    By:
    • Jacobs, Tom
    Publication type:
    Article
    21

    My worst biotech investment.

    Published in:
    Nature Biotechnology, 2006, v. 24, n. 4, p. 401, doi. 10.1038/nbt0406-401
    By:
    • Jacobs, Tom
    Publication type:
    Article
    22

    A rollercoaster ride.

    Published in:
    Nature Biotechnology, 2006, v. 24, n. 3, p. 284, doi. 10.1038/nbt0306-284
    By:
    • Jacobs, Tom
    Publication type:
    Article
    23
    24
    25

    Trials and error.

    Published in:
    Nature Biotechnology, 2005, v. 23, n. 12, p. 1481, doi. 10.1038/nbt1205-1481
    By:
    • Jacobs, Tom
    Publication type:
    Article
    26

    The number on biotech indexes.

    Published in:
    Nature Biotechnology, 2005, v. 23, n. 11, p. 1356, doi. 10.1038/nbt1105-1356
    By:
    • Jacobs, Tom
    Publication type:
    Article
    27

    A taxing dilemma.

    Published in:
    Nature Biotechnology, 2005, v. 23, n. 10, p. 1219, doi. 10.1038/nbt1005-1219
    By:
    • Jacobs, Tom
    Publication type:
    Article
    28
    29

    No pain, no gain?

    Published in:
    Nature Biotechnology, 2005, v. 23, n. 8, p. 934, doi. 10.1038/nbt0805-934
    By:
    • Jacobs, Tom
    Publication type:
    Article
    30

    When a long shot is worth a shot.

    Published in:
    Nature Biotechnology, 2005, v. 23, n. 7, p. 805, doi. 10.1038/nbt0705-805
    By:
    • Jacobs, Tom;
    • Fischer, Jeff
    Publication type:
    Article
    31
    32

    Beware the biotech barker.

    Published in:
    Nature Biotechnology, 2005, v. 23, n. 5, p. 538, doi. 10.1038/nbt0505-538
    By:
    • Jacobs, Tom
    Publication type:
    Article
    33

    Diversify to multiply.

    Published in:
    Nature Biotechnology, 2005, v. 23, n. 4, p. 419, doi. 10.1038/nbt0405-419
    By:
    • Jacobs, Tom
    Publication type:
    Article
    34
    35

    Great company, bad stock.

    Published in:
    Nature Biotechnology, 2005, v. 23, n. 2, p. 173, doi. 10.1038/nbt0205-173
    By:
    • Jacobs, Tom
    Publication type:
    Article
    36

    Time to kick that drug habit.

    Published in:
    Nature Biotechnology, 2005, v. 23, n. 1, p. 23, doi. 10.1038/nbt0105-23
    By:
    • Jacobs, Tom
    Publication type:
    Article
    37

    Biotechs for pennies?

    Published in:
    Nature Biotechnology, 2004, v. 22, n. 12, p. 1509, doi. 10.1038/nbt1204-1509
    By:
    • Jacobs, Tom
    Publication type:
    Article
    38

    The best companies bare all.

    Published in:
    Nature Biotechnology, 2004, v. 22, n. 11, p. 1363, doi. 10.1038/nbt1104-1363
    By:
    • Jacobs, Tom
    Publication type:
    Article
    39

    More than meets the eyes?

    Published in:
    Nature Biotechnology, 2004, v. 22, n. 10, p. 1221, doi. 10.1038/nbt1004-1221
    By:
    • Jacobs, Tom
    Publication type:
    Article
    40
    41

    Biotech IPOs--flop or pop?

    Published in:
    Nature Biotechnology, 2004, v. 22, n. 8, p. 949, doi. 10.1038/nbt0804-949
    By:
    • Jacobs, Tom
    Publication type:
    Article
    42

    Bargains in the basement.

    Published in:
    Nature Biotechnology, 2004, v. 22, n. 7, p. 813, doi. 10.1038/nbt0704-813
    By:
    • Jacobs, Tom
    Publication type:
    Article
    43

    Diversifying in biotech.

    Published in:
    Nature Biotechnology, 2004, v. 22, n. 6, p. 661, doi. 10.1038/nbt0604-661
    By:
    • Jacobs, Tom
    Publication type:
    Article
    44
    45
    46

    Biotech IPOs: handle with care.

    Published in:
    Nature Biotechnology, 2003, v. 21, n. 12, p. 1437, doi. 10.1038/nbt1203-1437
    By:
    • Jacobs, Tom
    Publication type:
    Article
    47
    48
    49

    Going short on biotech.

    Published in:
    Nature Biotechnology, 2003, v. 21, n. 10, p. 1133, doi. 10.1038/nbt1003-1133
    By:
    • Jacobs, Tom
    Publication type:
    Article
    50

    Is Elan a turnaround?

    Published in:
    Nature Biotechnology, 2003, v. 21, n. 9, p. 985, doi. 10.1038/nbt0903-985
    By:
    • Jacobs, Tom
    Publication type:
    Article